Increased Investment in R&D Activities to Put Mycoplasma Testing Market on a High Growth Trajectory

Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Logo

Hyderabad, India -- (SBWire) -- 02/05/2018 --Market Data Forecast has published a report on "Mycoplasma Testing Market By Product (Kits & Reagents, Instruments And Services), By Technique (PCR, ELSA, Direct Assays, Indirect Assays, Microbial Culture Techniques, Enzymatic Methods, And DNA Staining), By Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing And Others), By End User (Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes And Cell Banks) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)"

The global Mycoplasma testing is expected to reach a market value of USD 845 Million by 2022 at a CAGR of 12.7% from an estimated value of USD 465 Million in 2017.

Mycoplasma is a type of bacteria and they do not possess a cell wall or cell membrane. The presence of Mycoplasma can severely affect the cell culture development during laboratory activities. This contamination can be the result of bringing adulterated objects into the laboratory or it can be carried by a person entering the lab from outside. There are multiple ways to test for Mycoplasma in cell culture in order to prevent further contamination of the bacteria.

View Report Page: https://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/

The primary factors driving the Mycoplasma testing market are the increased R&D activities and growing support from the government towards research institutions through funding. The enhanced demand for innovations in medical research also has a positive effect on the market growth. Strict regulations by the government regarding the trials of new testing methods and the high cost of testing equipment are the main challenges faced by the market.

Request For Sample: https://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/request-sample

The global mycoplasma testing market is analysed across various segments based on products, techniques, applications, end-user and region. By product, the market is segregated into kits & reagents, instruments and services. Kits & reagent is expected to hold the largest market share in this segment.

Based on technique, the market figures are provided for ELSA, PCR, Direct Assays, Microbial culture techniques, Indirect Assays, Enzymatic Methods and DNA Staining. PCR technique is currently leading the market in this segment owing to its higher acceptance in life sciences research due to the flexibility and speed of this technique.

By application, the mycoplasma testing market is segmented as Cell Line Testing, Virus Testing, End-Of-Production Cell Testing and other applications. By end user, the market is categorized into Pharmaceutical Companies, Contract research organizations, Academic Research Institutes and Cell Banks. Pharmaceutical companies segment holds the largest market share due to the increasing R&D activities in pharmaceutical and biotechnology companies.

Regional Overview

By region, the market can be divided into North America, Latin America, Europe Middle East and Africa and Asia-Pacific. North America is leading the global market owing to the high number of research activities being carried out and funded by the government. North America is closely followed by Europe in terms of market value. Asia-Pacific is showing tremendous scope for the market growth with increasing awareness towards R&D in countries like China, Japan, and India.

Customize Report: https://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/customize-report

Some of the major manufacturers of Mycoplasma Testing Market are Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

Contact INFO
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

Media Relations Contact

Sai Kutumbarao
Business Development Executive
Market Data Forecast
1-888-702-9626
http://www.marketdataforecast.com/

View this press release online at: http://rwire.com/922923